(Q33619866)
Statements
PEGylation of interferon α2 improves lymphatic exposure after subcutaneous and intravenous administration and improves antitumour efficacy against lymphatic breast cancer metastases (English)
Victoria M McLeod
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference